Profil
Chuck Yon was the founder of Checkmate Pharmaceuticals, Inc. founded in 2015, where he held the title of General Counsel from 2015 to 2021.
Mr. Yon's former jobs include Secretary, Senior Vice President & General Counsel at Coley Pharmaceutical Group, Inc. from 2001 to 2008, and Senior Vice President & General Counsel at Astra Pharmaceutical Products, Inc. from 1989 to 1999.
Mr. Yon's education history includes a graduate degree from Georgetown University Law Center, an MBA from Kellogg School of Management, and a graduate degree from Harvard College.
Ehemalige bekannte Positionen von Chuck Yon
| Unternehmen | Position | Ende |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Gründer | 04.01.2021 |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | General Counsel | 01.01.2008 |
| Astra Pharmaceutical Products, Inc. | General Counsel | 01.01.1999 |
Ausbildung von Chuck Yon
| Harvard College | Graduate Degree |
| Georgetown University Law Center | Graduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
| Astra Pharmaceutical Products, Inc. |
